Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > price trend and the LIFE offering
View:
Post by DJDawg on Nov 14, 2023 9:11am

price trend and the LIFE offering

One more challenge that RDW is facing is that if the LIFE still trying to get new buyers who have never heard of TLT till now. However, those buyers are going to hear that the offering is for 0.22 per share and when you look at the price chart is is nothing but falling stock value for the last 12m. Not to mention the last few weeks.

I really doubt a newbie, who doesn't know MacFarland's science, is going to buy a 0.17 c stock for 0.22 when they look at the graph.

And I think everyone else who knows about TLT and wants in on the LIFE are in

So my prediction is that they will have to announce closing soon with whatever money they got.

sigh.
Comment by riverrrow on Nov 14, 2023 9:21am
My guess is that the opposite of your prediction will occur.  GLTA.
Comment by DJDawg on Nov 14, 2023 9:29am
Opposite is that they won't close the offering.....?
Comment by N0taP00p on Nov 14, 2023 9:34am
I got several friends to invest in this  company when it was in the 25 US cents range a while ago. And two family member a few years ago.  Told them good things were sure to come, and soon.  Three of them are still holding. It's no longer a topic of conversation.  Hoping for redemption soon, as much as I think your assessment is right DJD.   I'm in the " ...more  
Comment by DJDawg on Nov 14, 2023 9:45am
My assessment is not an optimistic one. It just seems that they are stuck. No one new is going to invest in LIFE looking at that chart. I hesitate to ever recommend this stock to anyone as the mix of good science and terrible management is hard. On that note, recall that the three prior small PP's were almost certainly to RDW's close contacts. Imagine how they all feel buying in at 0.25  ...more  
Comment by Legit62 on Nov 14, 2023 9:49am
Hate to agree with you DJDawg, but lack of keeping timelines and seeing this SP tank is definitely not drawing new investors. I feel as though if we by chance are able to close this one , we may be ok. It may take Roger ponying up some big money to keep us alive IMO
Comment by Alamir1111 on Nov 14, 2023 10:40am
Any positive news  right now would help a lot.. Maybe something is anticipated  and that is the reason of timing for this life financing?
Comment by lesflics on Nov 14, 2023 11:54am
People who have been in this stock for a long time have seen a lot of ups and downs. There have been many "the sky is falling" moments which the company has recovered from. We all knew before we invested that this was an extremely speculative investment - high risk and high potential reward. I'm sure many investors sold their positions at those previous low points, which was a ...more  
Comment by riverrrow on Nov 14, 2023 11:14am
Rumour has it that some of the previous pp participants have more than doubled up with this LIFE financing.  GLTA.
Comment by Oilminerdeluxe on Nov 14, 2023 11:18am
If true, good. 
Comment by FGPstock on Nov 14, 2023 9:48am
Poopy, I think we all put too many friends in this one. I am often reminded of the price and how my holdings r going. Something is off w this stock
Comment by BudFoxx2020 on Nov 14, 2023 9:42am
That is not how this financing works.  It won't close until the minimum is filled but the clock is ticking.  If they can't fill the minimum they will have to refund the money back to those that bought the financing at 0.22 cents.  This is my understanding from my DD.  I could be wrong.   Anyways, I wonder if RDW coming back as CEO from the OSC suspension ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250